| For: | He Q, Liu Y, Zou Q, Guan YS. Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma. World J Gastroenterol 2011; 17(18): 2353-2355 [PMID: 21633603 DOI: 10.3748/wjg.v17.i18.2353] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i18/2353.htm |
| Number | Citing Articles |
| 1 |
JUNFEN MA, JIMIN ZHAO, JING LU, YANAN JIANG, HONGYAN YANG, PEI LI, MINGYAO ZHAO, KANGDONG LIU, ZIMING DONG. Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer. International Journal of Molecular Medicine 2012; 30(6) doi: 10.3892/ijmm.2012.1133
|
| 2 |
Julia Reetz, Ottmar Herchenröder, Anke Schmidt, Brigitte M. Pützer. Regenerative Medicine. 2013; doi: 10.1007/978-94-007-5690-8_19
|
| 3 |
Yixin Duan, Haixia Bai, Xiang Li , Depu Wang , Ying Wang, Meng Cao, Nana Zhang, Hongwei Chen , Yili Wang. Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells. Current Cancer Drug Targets 2021; 21(7) doi: 10.2174/1568009621666210308103541
|
| 4 |
Xiao-jun Lin, Qi-jiong Li, Xiang-ming Lao, Han Yang, Sheng-ping Li. Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC). BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1715-x
|
| 5 |
L. Yi, Z. Ning, L. Xu, Y. Shen, X. Zhu, W. Yu, J. Xie, Z. Meng. The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study. ESMO Open 2024; 9(2) doi: 10.1016/j.esmoop.2024.102239
|
| 6 |
Wenlong Du, Jintong Na, Liping Zhong, Pumin Zhang. Advances in preclinical and clinical studies of oncolytic virus combination therapy. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1545542
|
| 7 |
Xiang Zhang, Yingchang Wang, Xiaojuan Lv, Fangfang Wang, Qiong Zhou, Feiya Zhang, Meng Zhang, Jianhong Chen. Intratumoral injection of oncolytic virus (H101) in combination with concurrent chemoradiotherapy for locally advanced cervical cancer. International Journal of Gynecological Cancer 2023; 33(7) doi: 10.1136/ijgc-2022-003914
|
| 8 |
Johanna Kusnick, Alix Bruneau, Frank Tacke, Linda Hammerich. Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma. Immuno 2022; 2(1) doi: 10.3390/immuno2010014
|
| 9 |
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn. Transcriptional regulators in hepatocarcinogenesis – Key integrators of malignant transformation. Journal of Hepatology 2012; 57(1) doi: 10.1016/j.jhep.2011.11.029
|
| 10 |
Changyou Jing, Tong Zhu, Yonghong Zhang, Jianjun Li. The combination treatment of oncolytic adenovirus H101 with transcatheter arterial embolization sequential thermal ablation for hepatocellular carcinoma: a retrospective study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1623877
|